Please login to the form below

Not currently logged in
Email:
Password:

ROCK names new managing director

Terence Bradley was previously founding director of Pollen Health

rock terrence bradleyROCK medical communications has named founding director of Pollen Health Terence Bradley as its new managing director.

Bradley replaces Eric Hansen, who left Creston Health company Rock earlier this year to become managing director of Creston's creative agency PAN.

Bradley served as managing director of Pollen from 2011 to the end of 2013, deciding to leave the agency after its parent company - Hive Group - was taken over by marketing and publishing firm St Ives Group.

During his time at Pollen Bradley built a client base that included clients such as Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Gilead and Nutricia.

His experience prior to Pollen includes the role of managing director for Cohn & Wolfe's healthcare business and senior business director at Ogilvy Healthworld. He also has experience at publishing firms The Lancet and Medpress.

Catherine Warne, Creston Health CEO, said: “He has an outstanding background in medical communications - having spent the last 27 years in medical communications and 13 years of that time in the agency world. He is a specialist in online learning, behaviour change and storytelling.”

12th November 2014

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics